Saxenda vs Wegovy Price: Why the Comparison Is More Complicated Than It Looks

The biggest misconception: that the cheaper injection is the better deal

The most common assumption when comparing Saxenda and Wegovy prices is that a lower monthly cost makes one a smarter financial choice. That framing misses something fundamental. Saxenda is a daily injection; Wegovy is once weekly. So a monthly Saxenda supply covers 28–31 daily doses, while Wegovy covers four weekly ones. The per-injection comparison looks very different from the per-pen one. On top of that, Saxenda requires a five-step dose escalation over roughly five weeks before reaching its full maintenance dose. Wegovy follows a slower titration, typically over about 16 weeks to the 2.4mg maintenance level. That difference in schedule affects how much medicine you consume in the first months, and therefore the true cost across a treatment course, not just the first month. If you want a clear picture of what you would actually pay, the Wegovy cost and price breakdown sets out what goes into the figure before you commit to anything.

UK private pricing for both medicines varies between providers, and any figure quoted without a breakdown of what it covers is not a meaningful comparison. According to the NHS patient information page on semaglutide, Wegovy is a once-weekly injection; the clinical evidence behind it comes from the STEP programme, which reported an average of around 15% body-weight reduction over 68 weeks in adults without type 2 diabetes.

Saxenda's clinical evidence is older and shows more modest average results. That disparity in effectiveness sits behind much of the price difference, and if you are trying to work out whether Saxenda genuinely works out cheaper than Wegovy once all the dose steps and appointment costs are counted, the answer is less obvious than the headline prices suggest. That makes it worth weighing when the question is value, not just cost.

Neither is the cheapest weight-loss option, and that matters less than you might think

Saxenda is not currently dispensed by nume for weight management. This page is here to help you understand the landscape, not to sell you either product. What we can say clearly: Wegovy is one of the two GLP-1 medicines licensed for weight management in the UK and dispensed through our pharmacy; Mounjaro (tirzepatide) is the other. Both are prescription-only. Both require clinical assessment before any supply.

When you compare prices across online providers for any of these medicines, a few things are routinely missing from the headline figure. Many providers charge separately for the initial consultation, the prescription itself, each dose-review appointment, aftercare support between doses, and delivery. Those additions can move the real monthly cost well above what the product listing suggests. If you want to understand what goes into the price of a Wegovy pen specifically, breaking it down by pen rather than by month makes the structure easier to follow.

Saxenda, despite often carrying a lower upfront price, is not cost-free to run. Daily injections mean a faster pen turnover; some providers charge for each consultation tied to a dose step. If those appointments are not included, a cheaper-looking starting point becomes a series of additional charges.

What the NICE guidance says, and why it shapes what you can access

Neither Saxenda nor Wegovy sits easily within standard NHS access for most people right now. NICE's appraisal of semaglutide for weight management (TA875) recommends Wegovy only within specialist weight management services and for a maximum of two years, with strict BMI and comorbidity criteria. Saxenda has no equivalent NICE technology appraisal for weight loss, and NHS access is even more limited. Waiting times for specialist services can be very long in most areas.

Private treatment through a regulated pharmacy is the practical route for most people who do not meet the NHS thresholds or cannot wait. For weight management, the two medicines available through nume are Wegovy and Mounjaro; Saxenda is not one of them. If your question is how much Wegovy actually costs through a legitimate UK pharmacy, our Wegovy pricing page covers the breakdown honestly. For a look at how specific Wegovy dose costs differ, the 1mg dose price context is a useful starting point if you are partway through a titration.

One thing worth knowing: from 1 September 2025, Eli Lilly raised the UK list price for the highest-dose Mounjaro pen substantially, with widely reported typical private prices now ranging roughly £149–£375 per month depending on dose and provider. Wegovy pricing has its own structure. Either way, the licensed supply chain is what determines whether what you receive is genuine medicine, something no comparison table can substitute for.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has warned repeatedly about counterfeit weight-loss pens sold without a prescription, including fake pens found to contain insulin. Around 20 million doses of illegally traded weight-loss medicines with a street value of approximately £45 million were seized in 2025 alone, and a UK manufacturing site producing counterfeit tirzepatide pens was raided in late 2025. Any seller offering GLP-1 medicines at prices far below the market norm, or with discount codes from an unverified source, is a red flag worth taking seriously. You can report suspect sellers at the MHRA's Yellow Card scheme.

At nume, one transparent price covers the prescriber consultation, the prescription, the medicine, and next-working-day DPD delivery. We are not the cheapest option. That is a deliberate decision: adding hidden fees would undercut the straightforwardness that makes a clinical service worth trusting. There are no subscriptions, no auto-renewals; every repeat order goes back to a prescriber for review before anything is dispatched. You can verify our pharmacy on the GPhC register, our premises registration number is 9012878, and the entry is publicly searchable at pharmacyregulation.org.

If you are eligible for Wegovy or Mounjaro through a private prescription and want to understand whether treatment through nume is right for you, the place to start is a free consultation, no commitment, reviewed personally by a GPhC-registered prescriber the same day you submit it.